PROGESTERONE
PROGESTERONE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PROGESTERONE; Generic name: PROGESTERONE; Drug class: Progesterone [EPC].
| Brand name | PROGESTERONE |
|---|---|
| Generic name | PROGESTERONE |
| Drug class | Progesterone [EPC] |
| Manufacturer | NuCare Pharmaceuticals,Inc. |
| Used for | INDICATIONS AND USAGE Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea. |
| Dosage | DOSAGE AND ADMINISTRATION Prevention of Endometrial Hyperplasia Progesterone capsules should be given as a single daily dose at bedtime, 200 mg orally for 12 days sequentially per 28-day cycle, to postmenopausal women with a uterus who are receiving daily conjugated estrogens tablets. Treatment of Secondary Amenorrhea Progesterone capsules may be given as a single daily dose of 400 mg at bedtime for 10 days. Some women may experience difficulty swallowing progesterone capsules. For these women, |
| Warnings | WARNINGS See BOXED WARNING . 1. Cardiovascular disorders An increased risk of pulmonary embolism, deep vein thrombosis (DVT), stroke, and myocardial infarction has been reported with estrogen plus progestin therapy. Should any of these occur or be suspected, estrogen with progestin therapy should be discontinued immediately. Risk factors for arterial vascular disease (for example, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, and obesity) and/or venous thromboembolism (for |
| Active ingredient(s) | PROGESTERONE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b3da881-4720-cdee-e063-6394a90aee99 |